Prevalence, volume, and clinical correlates of intracranial arteriosclerosis among patients with cognitive complaints: a clinic‐based study [PDF]
Abstract Background Intracranial arteriosclerosis increases the risk of dementia in the general population, but no published studies have determined its clinical value for the diagnosis of vascular cognitive impairment in a memory clinic setting. Method We included 317 patients (mean age: 69.9 years, 44% female) who attended the Erasmus MC Alzheimer ...
MERDASSA O +6 more
europepmc +4 more sources
Intracranial arteriosclerosis: determinants and clinical consequences [PDF]
Vaatverkalkingen, of arteriosclerose, zijn afzettingen van mineralen in het vaatstelsel, meestal in de vorm van hydroxyapatiet. In de vaatwant komen ze met name voor in atherosclerotische plaque in de tunica intima, of in de omliggende lamina elastica interna (IEL) of tunica media.
Tim Cornelis van den Beukel
openaire +4 more sources
Intracranial arteriosclerosis and the risk of dementia: A population‐based cohort study [PDF]
AbstractBACKGROUNDThe impact of intracranial arteriosclerosis on dementia remains largely unclear.METHODSIn 2339 stroke‐free and dementia‐free participants (52.2% women, mean age 69.5 years) from the general population, we assessed intracranial carotid artery calcification (ICAC) and vertebrobasilar artery calcification (VBAC) as proxy for ...
van den Beukel, Tim C. +7 more
openaire +4 more sources
Morphological Subtypes of Intracranial Internal Carotid Artery Arteriosclerosis and the Risk of Stroke [PDF]
Background: Accumulating evidence highlights the existence of distinct morphological subtypes of intracranial carotid arteriosclerosis. So far, little is known on the prevalence of these subtypes and subsequent stroke risk in the general population.
Tim C. van den Beukel +8 more
openaire +6 more sources
P2‐416: INTRACRANIAL ARTERIOSCLEROSIS AND BRAIN STRUCTURE IN AGING [PDF]
Elisabeth J. Vinke +8 more
openaire +2 more sources
Atherosclerosis enhances the efficacy of liposome-encapsulated bromocriptine in reducing the incidence of prolactinemia in pituitary tumors [PDF]
Intranasal drug delivery via nanocarriers has long been a research focus for enhancing drug concentration in the brain. However, the strategy of exploiting blood–brain barrier (BBB) alterations in atherosclerotic mouse models to enhance nanoparticle ...
Zhe Zhang +12 more
doaj +2 more sources
Ventriculomegaly without elevated intracranial pressure? Normal pressure hydrocephalus as a disorder of the cerebral windkessel [PDF]
ObjectiveNormal pressure hydrocephalus (NPH) is characterized by ventriculomegaly without elevations in intracranial pressure (ICP). One way of viewing hydrocephalus is as a disorder of the cerebral windkessel.
Racheed Mani +9 more
doaj +2 more sources
Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study [PDF]
Background and purpose The combination of PCSK9 inhibitors and moderate statin therapy effectively stabilizes intracranial atherosclerotic plaques in patients with intracranial atherosclerotic stenosis (ICAS).
Zhenzhen Li +14 more
doaj +3 more sources
Purpose: Little is known about quantification of intracranial arteriosclerosis in stroke patients. CT angiography (CTA) is becoming part of the routine CT stroke work-up and may offer a way to quantify intracranial calcium burden (Figure 1).
Nikola Gotovac
openaire +2 more sources
Review of theories into the pathogenesis of normal pressure hydrocephalus [PDF]
Normal pressure hydrocephalus (NPH) represents a unique form of hydrocephalus characterised by the paradox of ventriculomegaly without significant elevations in intracranial pressure, with the clinical triad of gait instability, cognitive impairment, and
Liu Yang +5 more
doaj +2 more sources

